Rupp, Christian

Patient age, sex, and inflammatory bowel disease phenotype associate with course of primary sclerosing cholangitis

Weismüller, T. J., Trivedi, P. J., Bergquist, A., Imam, M., Lenzen, H., Ponsioen, C. Y., Holm, K., Gotthardt, D., Färkkilä, M. A., Marschall, H.-U., et al. (2017) · Gastroenterology

Liver Diseases and ImmunityInflammatory Bowel Disease

Cited by 533

Biliary strictures and recurrence after liver transplantation for primary sclerosing cholangitis: a retrospective multicenter analysis

Hildebrand, T., Pannicke, N., Dechene, A., Gotthardt, D. N., Kirchner, G., Reiter, F. P., Sterneck, M., Herzer, K., Lenzen, H., Rupp, C., et al. (2016) · Liver Transplantation

Liver Diseases and ImmunityOrgan Transplantation Techniques and Outcomes

Cited by 162

Mismatch repair deficiency is a rare but putative therapeutically relevant finding in non-liver fluke associated cholangiocarcinoma

Goeppert, B., Roessler, S., Renner, M., Singer, S., Mehrabi, A., Vogel, M. N., Pathil, A., Czink, E., Köhler, B., Springfeld, C., et al. (2019) · British Journal of Cancer

Cholangiocarcinoma and Gallbladder Cancer StudiesGenetic factors in colorectal cancer

Cited by 108

Defining primary sclerosing cholangitis: results from an International Primary Sclerosing Cholangitis Study Group consensus process

Ponsioen, C. Y., Assis, D. N., Boberg, K. M., Bowlus, C. L., Deneau, M., Thorburn, D., Aabakken, L., Färkkilä, M., Petersen, B., Rupp, C., et al. (2021) · Gastroenterology

Liver Diseases and ImmunityPediatric Hepatobiliary Diseases and Treatments

Cited by 95

FUT2 and FUT3 genotype determines CA19-9 cut-off values for detection of cholangiocarcinoma in patients with primary sclerosing cholangitis

Wannhoff, A., Hov, J. R., Folseraas, T., Rupp, C., Friedrich, K., Anmarkrud, J. A., Weiss, K. H., Sauer, P., Schirmacher, P., Boberg, K. M., et al. (2013) · Journal of Hepatology

Cholangiocarcinoma and Gallbladder Cancer StudiesLiver Diseases and Immunity

Cited by 94

Cytoplasmic localization of the cell polarity factor scribble supports liver tumor formation and tumor cell invasiveness

Wan, S., Meyer, A., Weiler, S. M. E., Rupp, C., Tóth, M., Sticht, C., Singer, S., Thomann, S., Roessler, S., Schorpp‐Kistner, M., et al. (2018) · Hepatology

Hepatocellular Carcinoma Treatment and PrognosisHippo pathway signaling and YAP/TAZ

Cited by 79

Emotional processing theory put to test: A meta‐analysis on the association between process and outcome measures in exposure therapy

Rupp, C., Doebler, P., Ehring, T., & Vossbeck‐Elsebusch, A. N. (2017) · Clinical Psychology & Psychotherapy

Anxiety, Depression, Psychometrics, Treatment, Cognitive ProcessesPosttraumatic Stress Disorder Research

Cited by 76

Effects of tumor necrosis factor antagonists in patients with primary sclerosing cholangitis

Hedin, C. R. H., Sado, G., Ndegwa, N., Lytvyak, E., Mason, A., Montano-Loza, A., Gerussi, A., Saffioti, F., Thorburn, D., Nilsson, E., et al. (2020) · Clinical Gastroenterology and Hepatology

Inflammatory Bowel DiseaseLiver Diseases and Immunity

Cited by 52

Pruritus is associated with severely impaired quality of life in patients with primary sclerosing cholangitis

Gotthardt, D. N., Rupp, C., Bruhin, M., Schellberg, D., Weiss, K. H., Stefan, R., Donnerstag, N., Stremmel, W., Löwe, B., Juenger, J., et al. (2014) · European Journal of Gastroenterology & Hepatology

Liver Diseases and ImmunityInflammatory Bowel Disease

Cited by 41

Fut2 genotype is a risk factor for dominant stenosis and biliary candida infections in primary sclerosing cholangitis

Rupp, C., Friedrich, K., Folseraas, T., Wannhoff, A., Bode, K. A., Weiss, K. ‐., Schirmacher, P., Sauer, P., Stremmel, W., & Gotthardt, D. N. (2014) · Alimentary Pharmacology & Therapeutics

Liver Diseases and ImmunityPediatric Hepatobiliary Diseases and Treatments

Cited by 38

Risk factors and outcome in patients with primary sclerosing cholangitis with persistent biliary candidiasis

Rupp, C., Bode, K. A., Chahoud, F., Wannhoff, A., Friedrich, K., Weiss, K.-H., Sauer, P., Stremmel, W., & Gotthardt, D. N. (2014) · BMC Infectious Diseases

Liver Diseases and ImmunityPediatric Hepatobiliary Diseases and Treatments

Cited by 38

Inflammation but not biliary obstruction is associated with carbohydrate antigen 19-9 levels in patients with primary sclerosing cholangitis

Wannhoff, A., Rupp, C., Friedrich, K., Brune, M., Knierim, J., Flechtenmacher, C., Sauer, P., Stremmel, W., Hov, J. R., Schirmacher, P., et al. (2015) · Clinical Gastroenterology and Hepatology

Liver Diseases and ImmunityGallbladder and Bile Duct Disorders

Cited by 34

Longitudinal analysis of CA19-9 reveals individualised normal range and early changes before development of biliary tract cancer in patients with primary sclerosing cholangitis

Wannhoff, A., Brune, M., Knierim, J., Weiss, K. H., Rupp, C., & Gotthardt, D. N. (2019) · Alimentary Pharmacology & Therapeutics

Liver Diseases and ImmunityCholangiocarcinoma and Gallbladder Cancer Studies

Cited by 17

Comparative effectiveness of medical treatment vs. metabolic surgery for histologically proven non-alcoholic steatohepatitis and fibrosis: a matched network meta-analysis

Billeter, A. T., Reiners, B., Seide, S. E., Probst, P., Kalkum, E., Rupp, C., & Müller-Stich, B. P. (2022) · Hepatobiliary Surgery and Nutrition

Liver Disease Diagnosis and TreatmentBariatric Surgery and Outcomes

Cited by 12